CD274 and neoplasm: In this regard, researchers speculated that the anti-tumor cytotoxicity of T cells infiltrated in the tumor microenvironment could be reflected by the reinvigoration status of circulating PD-1+ CD8+ T cells during anti-PD-(L)1 immunotherapy.